Pathological and biochemical studies of mucopolysaccharidosis type IIIB (Sanfilippo syndrome type B) in juvenile emus (Dromaius novaehollandiae).
Mucopolysaccharidosis (MPS) type IIIB was diagnosed in 14 juvenile emus (Dromaius novaehollandiae), ages 3 weeks to 6 months, based on pathological and biochemical analyses. The animals had a history of neurological signs or sudden death; one of the birds with neurological signs and 3 others experienced acute hemoabdomen. Histopathologically, neuronal swelling and vacuolation in the cerebrum, cerebellum, brainstem, and spinal cord (80%-92%); retina (100%); autonomic ganglia of the intestine (71%); gizzard (50%); adrenal gland (27%); and ear (50%) were noted in affected but not healthy emus. Cytoplasmic vacuoles were also observed in the pancreas, liver, intestine, adrenal glands, and kidneys. The intracytoplasmic inclusions were periodic acid-Schiff and Luxol Fast Blue positive, consistent with a storage disease. Foamy macrophages infiltrated the liver, intestine, tunica media of the aorta, and spleen. By transmission electron microscopy, typical lamellated cytoplasmic bodies were detected in neurons of the brain and retina, while electron-dense bodies consistent with glycosaminoglycan inclusions were observed in hepatocytes and/or hepatic macrophages. The livers of the 2 affected emus studied contained large amounts of heparan sulfate, which is suggestive of MPS type III. Compared with normal controls, hepatic and serum α-N-acetylglucosaminidase activity was very low (<8% of control), while other enzyme activities were normal to increased in the 2 affected emus studied. Moreover, affected emus were homozygous for a 2-bp deletion in the NAGLU gene. This study characterizes the pathology of MPS type IIIB in emus, which is one of the rare inborn errors in birds, showing the homology of this condition to Sanfilippo syndrome in humans.
School of Veterinary Science, The University of Queensland, Gatton Campus, Gatton, QLD Australia.
C
C
Palmieri
Section of Medical Genetics, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA, USA.
U
U
Giger
Section of Medical Genetics, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA, USA.
P
P
Wang
Department of Animal Medicine and Surgery (Service of Pathology), Veterinary School, Complutense University, Madrid, Spain.
M
M
Pizarro
California Animal Health and Food Safety Laboratory System, Tulare Branch, School of Veterinary Medicine, University of California, Davis, Tulare, CA, USA hlshivaprasad@ucdavis.edu.
H L
HL
Shivaprasad
D000118:Acetylglucosaminidase / Q000378:metabolism; D000818:Animals; D001715:Bird Diseases / Q000473:pathology*; D001921:Brain / Q000473:pathology; D020312:Dromaiidae; D006025:Glycosaminoglycans / Q000378:metabolism; D002479:Inclusion Bodies / Q000378:metabolism; D009084:Mucopolysaccharidosis III / Q000473:pathology / Q000662:veterinary*; D009474:Neurons / Q000473:pathology; D017384:Sequence Deletion
D006025:Glycosaminoglycans; C033079:alpha-N-acetyl-D-glucosaminidase; D000118:Acetylglucosaminidase
emu; histology; mucopolysaccharidosis type IIIB; nervous system; storage disease; transmission electron microscopy; α-N-acetylglucosaminidase